According to the new research report The Pharmaceutical Excipients Market by Products, published by MarketsandMarkets, the pharmaceutical excipients market was valued at $5,760.0 million in 2013 and is expected to grow at a healthy CAGR of 6.7% from 2014 to 2019.
The pharmaceutical excipients market has witnessed a strong growth over the past few years. Investments by the pharmaceutical manufacturers on novel method of drug delivery have propelled the growth of this market. Further, rising focus on development of biologics and new excipients will also drive the excipients market during the forecast period. Recently, functional excipients have gained greater focus due to their applications in formulations employing newly developed active pharmaceutical ingredients. However, declining investments on R&D by excipients manufacturers, and stringent regulatory requirements curbing the number of the U.S. FDA approved manufacturing sites are factors that inhibit the growth of this market to a certain extent.
North America is a major market for global pharmaceutical excipients which occupied a major share in this market, closely followed by Europe. Growth in investments on novel drug, and continuous efforts of pharmaceutical companies to offer superior-quality products are factors that have led to the large market shares of the North American and European pharmaceutical excipients markets.
The major players in the Pharmaceutical Excipients Market are Ashland Inc. (U.S.), BASF SE (Germany), The Dow Chemical Company (U.S.), Roquette (France), Colorcon, Inc. (U.S.), Avantor Performance Materials, Inc. (U.S.), FMC Corporation (U.S.), Evonik Industries (Germany), and Lubrizol Corporation (U.S.).
Full report title:
The Pharmaceutical Excipients Market by Products, (Organic chemicals, Inorganic Chemicals), Functionality (Fillers, Binders, Lubricants, Preservatives), & by Route of Administration (Oral, Topical, Parenteral, Others) - Global Forecast to 2019
